Oxycodone Market Revenue to outshine USD 6.4 BN BY 2026
Posted On June 16, 2020
The Global Oxycodone Market revenue is valued closely at USD 4.8 BN in 2019 and is anticipated to grow at USD 6.4 BN by 2026 with a CAGR of 4.2% during the year 2020-2026 as per the report published by Value Market Research. Oxycodone is an opioid analgesics drug. It is prescribed to help relieve moderate to severe pain. It is indicated for pain management those who cannot be treated with other medications. It is available in five forms: immediate-release tablet, extended-release tablet, immediate-release capsule, extended-release capsule, and solution. It is sold as a generic drug under the brand name: Roxicodone, Roxy bond, Oxaydo and Oxy Contin.
The growing ageing population and the prevalence of chronic diseases in humans are increasing the demand for oxycodone. Three in five of older above 65 years say that they experienced pain that lasts for a year or more, commonly attributable to arthritis or substantial daily pain. This will place a huge demand for oxycodone. The growing number of cancer treatments will increase the demand for oxycodone for pain management. Increased prescriptions of oxycodone will remain the largest contributor to the sales growth of the aforementioned medication. However, if oxycodone is taken in combination with other medications increases the risk of serious or life-threatening respiratory syndrome, sedation, or coma. Also, many countries are dealing with issues of misuse, addiction and illegal diversion of prescriptions. This might decline the prescription of oxycodone.
The "Global Oxycodone Market Report By Product Type (Long Acting Oxycodone And Short Acting Oxycodone), By Application (Hospital Pharmacies, Retail Pharmacies And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026" provides statistical data on the basis of revenue/or volume as well as qualitative data gathered from reliable sources. The report is segmented into chapters analyzing all the segments individually and regional bifurcation is also done in detail.
By product type the market is divided into long acting oxycodone and short acting oxycodone. On the basis of application the oxycodone market is divided into hospital pharmacies, retail pharmacies and others.
The regions - North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa are deeply studied with respect to all the oxycodone market segments covered in the report. The regional research assists in taking informed decision related to the regional strategic plans.
The Report Segments Global Oxycodone Market -
By Product Type
- Long Acting Oxycodone
- Short Acting Oxycodone
- Hospital Pharmacies
- Retail Pharmacies
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Players Profiled In the Report:
Johnson & Johnson, Sanofi, Pfizer, Purdue Pharma, Endo International, Teva Pharmaceuticals, Hikma Pharmaceuticals, Mallinckrodt, Mylan, Sun Pharmaceutical, Impax Laboratories and Indivior.
Download the FREE SAMPLE of Global Oxycodone Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]